Success Metrics

Clinical Success Rate
94.4%

Based on 17 completed trials

Completion Rate
94%(17/18)
Active Trials
6(23%)
Results Posted
35%(6 trials)
Terminated
1(4%)

Phase Distribution

Ph phase_2
1
4%
Ph phase_3
1
4%
Ph not_applicable
24
92%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution26 total trials
Phase 2Efficacy & side effects
1(3.8%)
Phase 3Large-scale testing
1(3.8%)
N/ANon-phased studies
24(92.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

94.4%

17 of 18 finished

Non-Completion Rate

5.6%

1 ended early

Currently Active

6

trials recruiting

Total Trials

26

all time

Status Distribution
Active(7)
Completed(17)
Terminated(1)
Other(1)

Detailed Status

Completed17
Recruiting5
Active, not recruiting1
unknown1
Terminated1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
26
Active
6
Success Rate
94.4%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (3.8%)
Phase 31 (3.8%)
N/A24 (92.3%)

Trials by Status

active_not_recruiting14%
unknown14%
terminated14%
not_yet_recruiting14%
completed1765%
recruiting519%

Recent Activity

Clinical Trials (26)

Showing 20 of 26 trialsScroll for more
NCT06449677Phase 3

Bionic Pancreas in CFRD

Recruiting
NCT07226583Not Applicable

Using a Personalized Decision Support Tool to Help People With Type 1 Diabetes Manage Exercise

Not Yet Recruiting
NCT06894849Not Applicable

Text -Based Depression Screening Among Cancer Survivors

Recruiting
NCT05191446Not Applicable

Coronavirus Disease 2019 (Covid-19) Impact on Alcohol-related Liver Disease Patient Outcomes, Care and Alcohol Use

Active Not Recruiting
NCT03326713Not Applicable

Genetic Risk Assessment for Cancer Education and Empowerment (GRACE) Project

Completed
NCT06483035Not Applicable

Treatment of Phantom Limb Pain by Intensive Visual Simulation Therapy

Recruiting
NCT04200313Not Applicable

The Insulin-Only Bionic Pancreas Pivotal Trial

Completed
NCT03345563Not Applicable

Project HERO: Health Empowerment & Recovery Outcomes

Completed
NCT06062303Not Applicable

Hemodynamic Phenotype-Based,Capillary Refill Time-Targeted Resuscitation In Early Septic Shock:ANDROMEDA-SHOCK-2

Recruiting
NCT05057611Not Applicable

Hemodynamic Phenotype and Capillary Refill Time-targeted Resuscitation Strategy

Recruiting
NCT02696382Not Applicable

Improving Function in Older Veterans With Hospital-Associated Deconditioning

Completed
NCT06053346Not Applicable

Partners in Wellness: Evaluation of a Pay for Performance Program for High-Utilizers of Mental Health Services

Completed
NCT03283657Not Applicable

Diabetes Risk Education and Communication Trial

Completed
NCT02611076Not Applicable

Smoking-cessation: A Spanish-Language Clinical Trial

Completed
NCT04936906Not Applicable

Mohs Surgery: Patient Satisfaction & Quality of Life (QOL)

Completed
NCT03878186Not Applicable

Efficacy Of A Cognitive Behavioral Therapy To Decrease Threat Appraisal In HIV Participants Initiating Antiretroviral

Unknown
NCT02276664Not Applicable

Capitalizing on a Teachable Moment to Promote Smoking Cessation

Completed
NCT01556581Not Applicable

Comparative Effectiveness of Early Physical Therapy Versus Usual Care for Low Back Pain

Completed
NCT03417219Not Applicable

Mobile Tablet Education to Advance Caregiver Health

Completed
NCT03372018Not Applicable

Promotora-Led Intervention for Metabolic and Mental Health

Completed

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
26